3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Parotid Neoplasms
1
Parathyroid Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroendocrine Tumors
1
Neoplasms, Unknown Primary
1
Interventions
Blood Specimen Collection
7
Drug Therapy
6
Surveys and Questionnaires
5
Radiotherapy
5
Radiosurgery
5
Docetaxel
5
Therapeutics
4
Specimen Handling
4
Immunotherapy
4
Hepatectomy
4
exemestane
3
enzalutamide
3
apalutamide
3
Trastuzumab
3
Hematologic Tests
3
Data Collection
3
Biopsy
3
Biological Assay
3
Anastrozole
3
Abiraterone Acetate
3
trastuzumab deruxtecan
2
palbociclib
2
darolutamide
2
abiraterone
2
abemaciclib
2
Wearable Electronic Devices
2
Triptorelin Pamoate
2
Tamoxifen
2
Surgical Procedures, Operative
2
Radiotherapy, Intensity-Modulated
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Neoplasm Metastasis
×
Biological Therapy
×
Clear all
NCT07111104
2025-08-08
ARIS
Hopitaux Prives de Metz, Groupe UNEOS
Completed
350 enrolled